ScholarIQanswers from OpenAlex

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

PaperCitations, authors & open-access status

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis have?

ScholarIQcitation count

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis has 1,009 citations in the OpenAlex counts ScholarIQ stores.

When was Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis published?

ScholarIQyear

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis has 2018 year in the ScholarIQ index.

What is the open-access status of Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis?

ScholarIQoa status

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis has closed oa status in the ScholarIQ index.

What is the DOI of Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis?

ScholarIQdoi

The DOI for Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis is on the source record.

What is the PMID of Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis?

ScholarIQpmid

The PMID for Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis is on the source record.

What is the OpenAlex record for Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis?

ScholarIQopenalex

The OpenAlex for Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial